Caffeine Citrate for Apnea of Prematurity: A Prospective, Open-Label, Single-Arm Study in Chinese Neonates

Background: Caffeine citrate has been approved in China for the management of apnea of prematurity. This clinical trial was conducted as a condition of regulatory approval. The aim was to confirm the efficacy of caffeine citrate in the treatment of recurrent intermittent hypoxia and bradycardia in p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pediatr
Autors principals: Du, Lizhong, Tong, Xiaomei, Chen, Chao, Gao, Xirong, Gagnatelli, Alessandra, Li, Jingyang, Santoro, Debora, Nicolardi, Sara, Fabbri, Laura
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Pediatrics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7078308/
https://ncbi.nlm.nih.gov/pubmed/32219085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2020.00076
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars